Has Shayna Glista received payments from drug or device companies?

Yes. Drug and device makers reported $5,902 in general payments to Shayna Glista across 362 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shayna Glista did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shayna Glista come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shayna Glista

Psychiatric/Mental Health · Beachwood, OHNPI 1679125876

Payments from drug & device makers

$5,902in general payments, 2019–2025

Across 362 payments — averaging $16.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$825
AbbVie$802
Corium, LLC$777
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$661
Tris Pharma Inc$632
Alkermes, Inc.$597
plus $2K from 12 others

What the payments were for

Food & beverage$5,84199%
Education$611%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	51	$825
AbbVie	50	$802
Corium, LLC	46	$777
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	41	$661
Tris Pharma Inc	61	$632
Alkermes, Inc.	16	$597
Vanda Pharmaceuticals Inc.	33	$417
Axsome Therapeutics, Inc.	17	$353
Lundbeck LLC	18	$300
Johnson & Johnson	4	$121
Almatica Pharma LLC	6	$111
Takeda Pharmaceuticals U.S.A., Inc.	5	$77
Supernus Pharmaceuticals, Inc.	4	$71
Ironshore Pharmaceuticals Inc.	3	$50
Neurocrine Biosciences, Inc.	2	$38
E.r. Squibb & Sons, L.L.C.	2	$30
Collegium Pharmaceutical, Inc.	2	$28
Bausch Health US, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,902 in reported general payments places this provider in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	40	$59,682
Invega SustennaPaliperidone Palmitate	13	$30,535
TrintellixVortioxetine Hydrobromide	22	$10,440
Loreev XrLorazepam	12	$4,589
VyvanseLisdexamfetamine Dimesylate	11	$4,195
Duloxetine Hcl	50	$1,268
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	28	$1,176
Mirtazapine	56	$970
Methylphenidate ErMethylphenidate Hcl	12	$949
Venlafaxine Hcl ErVenlafaxine Hcl	35	$792
Bupropion XlBupropion Hcl	20	$685
Lurasidone Hcl	24	$676
Quetiapine Fumarate	44	$625
Lamotrigine	48	$547
Buspirone Hcl	36	$532

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$802	$59,68240 claims
Johnson & JohnsonInvega Sustenna	$121	$30,53513 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse	$77	$14,63533 claims
Almatica Pharma LLCLoreev Xr, Sertraline Hcl	$111	$4,93456 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Beachwood

Crystal TravisJackson$333K
Kristina RoweIronton$253K
Patricia SparksPortsmouth$210K
Mary HallWarren$195K
Kassandra KornbauCanfield$170K
Terri PopovitzCincinnati$161K
Steven MatesDayton$121K
Robert ParsonsYoungstown$119K
Chriscia BaneChillicothe$115K
Rachael McLaughlinMaple Heights$114K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →